176 related articles for article (PubMed ID: 19830726)
1. Reassessing the role of HLA-DRB3 T-cell responses: evidence for significant expression and complementary antigen presentation.
Faner R; James E; Huston L; Pujol-Borrel R; Kwok WW; Juan M
Eur J Immunol; 2010 Jan; 40(1):91-102. PubMed ID: 19830726
[TBL] [Abstract][Full Text] [Related]
2. Complementarity and redundancy of the binding specificity of HLA-DRB1, -DRB3, -DRB4 and -DRB5 molecules.
Texier C; Pouvelle-Moratille S; Busson M; Charron D; Ménez A; Maillère B
Eur J Immunol; 2001 Jun; 31(6):1837-46. PubMed ID: 11433380
[TBL] [Abstract][Full Text] [Related]
3. Characterization of Magnitude and Antigen Specificity of HLA-DP, DQ, and DRB3/4/5 Restricted DENV-Specific CD4+ T Cell Responses.
Grifoni A; Moore E; Voic H; Sidney J; Phillips E; Jadi R; Mallal S; De Silva AD; De Silva AM; Peters B; Weiskopf D; Sette A
Front Immunol; 2019; 10():1568. PubMed ID: 31333679
[No Abstract] [Full Text] [Related]
4. Functional dissection of the serological DR LYGUE and genotypic DRB1*1303 specificities using a tetanus toxin-specific T-cell clone.
Martínez-Soria E; Tiercy JM; Beffy P; Taban-Marín P; Jaques D; Bétuel H; Jeannet M; Mach B; Irlé C
Tissue Antigens; 1993 Sep; 42(3):118-24. PubMed ID: 8284784
[TBL] [Abstract][Full Text] [Related]
5. Identification of two new alleles HLA-DRB1*0312, DRB1*0432 and of a DRB3-negative DRB1*1313-positive haplotype.
Anholts JD; Verduijn W; Drabbels J; Mulder A; Doxiadis II; Schreuder GM
Tissue Antigens; 2000 Jul; 56(1):87-9. PubMed ID: 10958361
[TBL] [Abstract][Full Text] [Related]
6. DR-restricted T-cell reactivities associated with the Dw19 specificity can be directed against the products of either locus DRB3 (DRw52c) or locus DRB1.
Zeliszewski D; Tiercy JM; Dorval I; Kaplan C; Mach B; Sterkers G
Hum Immunol; 1990 Aug; 28(4):345-53. PubMed ID: 2391250
[TBL] [Abstract][Full Text] [Related]
7. Six newly identified HLA-DRB alleles: DRB1*1121, *1419, *1420, *1421, DRB3*0203 and DRB5*0103.
Verduyn W; Anholts JD; Versluis LF; Parlevliet J; Drabbels J; De Meester J; Tilanus MG; Doxiadis II; Giphart MJ; Schreuder GM
Tissue Antigens; 1996 Aug; 48(2):80-6. PubMed ID: 8883296
[TBL] [Abstract][Full Text] [Related]
8. Sharing of four DR-beta sequence motifs between HLA-DRB1*1601 and DRB1*1101 correlates with frequent degenerate T-cell recognition of HA306-320 peptide complexed to these two molecules.
Zeliszewski D; Dorval I; Golvano JJ; Prevost A; Borras-Cuesta F; Sterkers G
Scand J Immunol; 1996 Feb; 43(2):146-54. PubMed ID: 8633194
[TBL] [Abstract][Full Text] [Related]
9. HLA-DRB1, -DRB3, -DRB4 and -DRB5 genotyping at a super-high resolution level by long range PCR and high-throughput sequencing.
Ozaki Y; Suzuki S; Shigenari A; Okudaira Y; Kikkawa E; Oka A; Ota M; Mitsunaga S; Kulski JK; Inoko H; Shiina T
Tissue Antigens; 2014 Jan; 83(1):10-6. PubMed ID: 24355003
[TBL] [Abstract][Full Text] [Related]
10. Primate DRB genes from the DR3 and DR8 haplotypes contain ERV9 LTR elements at identical positions.
Svensson AC; Setterblad N; Sigurdardóttir S; Rask L; Andersson G
Immunogenetics; 1995; 41(2-3):74-82. PubMed ID: 7806299
[TBL] [Abstract][Full Text] [Related]
11. The different level of expression of HLA-DRB1 and -DRB3 genes is controlled by conserved isotypic differences in promoter sequence.
Emery P; Mach B; Reith W
Hum Immunol; 1993 Oct; 38(2):137-47. PubMed ID: 8106268
[TBL] [Abstract][Full Text] [Related]
12. A novel DRB1*0801 haplotype carrying DRB3*0202 found in a German pedigree.
Chen DF; Pastucha LT; Albert ED; Seibert I; Volgger A; Yao Z; Pein CD; Tillmann HL; Manns MP; Stangel W
Eur J Immunogenet; 1997 Dec; 24(6):435-7. PubMed ID: 9534042
[TBL] [Abstract][Full Text] [Related]
13. Description of fourteen new DRB alleles found in a stem cell donor registry.
Tang TF; Lin YS; Robbins FM; Li L; Sintasath D; Coquillard G; Huang A; Heine U; Ng J; Hartzman RJ; Hurley CK
Tissue Antigens; 2002 Jan; 59(1):63-5. PubMed ID: 11972885
[TBL] [Abstract][Full Text] [Related]
14. T cell epitopes of human myelin oligodendrocyte glycoprotein identified in HLA-DR4 (DRB1*0401) transgenic mice are encephalitogenic and are presented by human B cells.
Forsthuber TG; Shive CL; Wienhold W; de Graaf K; Spack EG; Sublett R; Melms A; Kort J; Racke MK; Weissert R
J Immunol; 2001 Dec; 167(12):7119-25. PubMed ID: 11739534
[TBL] [Abstract][Full Text] [Related]
15. Associations of human leukocyte antigen DRB with resistance or susceptibility to HIV-1 infection in the Pumwani Sex Worker Cohort.
Lacap PA; Huntington JD; Luo M; Nagelkerke NJ; Bielawny T; Kimani J; Wachihi C; Ngugi EN; Plummer FA
AIDS; 2008 May; 22(9):1029-38. PubMed ID: 18520346
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic recognition of HLA-DRB1*0406 by T cells with HLA-DRB1*0403: role of amino acid residue 37 on the beta sheet in T cell recognition.
Kaneko T; Obata F
Immunobiology; 1996 Aug; 195(3):261-70. PubMed ID: 8877401
[TBL] [Abstract][Full Text] [Related]
17. Identification of new MHC-restriction elements for presentation of the p210(BCR-ABL) fusion region to human cytotoxic T lymphocytes.
Sun JY; Senitzer D; Forman SJ; Chatterjee S; Wong KK
Cancer Immunol Immunother; 2003 Dec; 52(12):761-70. PubMed ID: 14564482
[TBL] [Abstract][Full Text] [Related]
18. Quantitative analysis of the expression of the HLA-DRB genes at the transcriptional level by competitive polymerase chain reaction.
Vincent R; Louis P; Gongora C; Papa I; Clot J; Eliaou JF
J Immunol; 1996 Jan; 156(2):603-10. PubMed ID: 8543811
[TBL] [Abstract][Full Text] [Related]
19. HLA-DRB1*08, DRB1*03/DRB3*0101, and DRB3*0202 are susceptibility genes for Graves' disease in North American Caucasians, whereas DRB1*07 is protective.
Chen QY; Huang W; She JX; Baxter F; Volpe R; Maclaren NK
J Clin Endocrinol Metab; 1999 Sep; 84(9):3182-6. PubMed ID: 10487684
[TBL] [Abstract][Full Text] [Related]
20. Next-Generation Sequencing Reveals That HLA-DRB3, -DRB4, and -DRB5 May Be Associated With Islet Autoantibodies and Risk for Childhood Type 1 Diabetes.
Zhao LP; Alshiekh S; Zhao M; Carlsson A; Larsson HE; Forsander G; Ivarsson SA; Ludvigsson J; Kockum I; Marcus C; Persson M; Samuelsson U; Örtqvist E; Pyo CW; Nelson WC; Geraghty DE; Lernmark Å;
Diabetes; 2016 Mar; 65(3):710-8. PubMed ID: 26740600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
